GO
Loading...

Amgen Inc

More

  • Pops & Drops: U.S. Steel, Thornburg Mortgage... Tuesday, 11 Mar 2008 | 6:34 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of U.S. Steel and Thornburg Mortgage popped while UnitedHealth and Dick's Sporting Goods dropped.

  • Stocks Have Their Best Day in Five Years Tuesday, 11 Mar 2008 | 4:55 PM ET

    Stocks shot up Tuesday after a liquidity announcement from the Federal Reserve.

  • Amgen, Johnson & Johnson & The FDA Tuesday, 11 Mar 2008 | 1:23 PM ET

    Shares of biotech giant Amgen fell as low as $43.14 (a new bottom) this morning after the briefing documents for Thursday's Food and Drug Administration Advisory Committee meeting were posted on the agency's website.

  • Dow Jumps 2%, Led by Financials Tuesday, 11 Mar 2008 | 11:10 AM ET

    Stocks shot up Tuesday after a liquidity announcement from the Federal Reserve.

  • Big Week For Biotech Monday, 10 Mar 2008 | 6:46 PM ET

    This is a big week for the world's top-two biotechnology companies and their investors. What’s going on and how can you trade it?

  • One Giant Leap for MannKind Monday, 10 Mar 2008 | 5:11 PM ET

    Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.

  • Amgen And Genentech: A Big Biotech Double Play Monday, 10 Mar 2008 | 10:50 AM ET
    AMGEN

    This is a big week for the world's top-two biotechnology companies and their investors. Amgen goes before an FDA Advisory Committee Thursday about the side effects of its bread-and-butter franchise Aranesp.

  • Next Weeks Trades: Wal-Mart, Costco & More Friday, 7 Mar 2008 | 7:28 PM ET

    In Friday’s Web Extra find out how the traders recommend playing Wal-Mart, Costco, Pfizer, Amgen and Genentech in the week ahead.

  • Tech's 'Horses' Hold Nasdaq Hostage in Bear Market Friday, 7 Mar 2008 | 1:46 PM ET
    bull and bear outside frankfurt stock exchange

    Nasdaq's bear market is likely to persist longer than the pullback in the broader stock market unless the recently battered technology heavyweights make solid comebacks.

  • Analyst: Pfizer Should Buy Amgen or Wyeth Friday, 7 Mar 2008 | 10:48 AM ET

    I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...

  • Drug Money Still A "Healthy Flow" To Democrats Monday, 3 Mar 2008 | 9:29 AM ET

    On the eve of the make-or-break Texas-Ohio primaries for Sen. Hillary Clinton, she remains in first place in at least one "poll." The Center for Responsive Politics has updated its list of top pharmaceuticals/health products-industry money recipients based on the most recent campaign finance reports and the former First Lady edges out Sen. Barack Obama...

  • Lightning Round: Medco, Amgen, Yum! and More Thursday, 28 Feb 2008 | 8:12 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Fund Manager: Buy Fast -- and Buy These Names Tuesday, 26 Feb 2008 | 3:29 PM ET

    The time to buy stocks, says Michael Cuggino, is now. The president and portfolio manager of Permanent Portfolio Funds offered CNBC very specific reasons to buy -- and the specific stocks you need.

  • Coffee Talk With Amgen And Roche Wednesday, 20 Feb 2008 | 3:15 PM ET

    Perhaps this item belongs in the "Funny Business" blog of my witty colleague Jane Wells, but when I saw this headline cross the Dow Jones Newswire this afternoon under the "Market Talk" blurb they move several times during the trading day, I just had to throw it up on my blog. I didn't know DJ had hired "Linda Richman" to write copy, or maybe Mike Myers needs a little extra income.

  • Genentech, JNJ, Pfizer: Big Days Ahead For Pharma Friday, 15 Feb 2008 | 9:41 AM ET

    Taking an extra day off to extend the long weekend before we go into a very busy period. Possibly a week from today (Friday) Genentech could get word from the Food and Drug Administration on its cancer drug Avastin for breast cancer. The agency could approve it, reject it or delay making a decision.

  • Stock Picks Your Portfolio Might Love Thursday, 14 Feb 2008 | 6:02 PM ET

    Stocks are down this Valentine's Day, and there's nothing to love about that.  To keep investors from getting their hearts broken by their portfolios, CNBC enlisted the help of market experts.

  • Buying Biotechs? Watch the Headlines Thursday, 14 Feb 2008 | 12:41 PM ET

    How should an investor play biotech stocks?  Pay attention to individual events involving individual companies, according to Bear Stearns biotech analyst Mark Schoenebaum.

  • World's Biggest Biotech Wednesday, 13 Feb 2008 | 6:45 PM ET

    Amgen, the biggest biotech by revenue, is trying to regain investors' confidence after a 32% drop in the last year. How should you trade?

  • In their stump speeches and debates, Hillary Clinton and Barack Obama often talk about pushing back against the Washington influence of the powerful pharmaceutical lobby and keeping drug company profits in check.

  • Glaxo, Merck, SGP & Amgen: Readers Have a Lot to Say Friday, 1 Feb 2008 | 10:51 AM ET

    It's a new month. Time to clean out the inbox. Regarding my post earlier this week about Sen. Chuck Grassley's office breaking the "Nature" embargo on the leak of the GlaxoSmithKline Avandia study, I heard from the "Nature" article reporter.